Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Wilson Therapeutics

October 20, 2015
Wilson Therapeutics Appoints Andrew Kay as Chairman
Wilson Therapeutics AB, a privatelyheld biopharmaceutical company, today announced that Andrew Kay has been appointed as Chairman of its Board of Directors. The company’s previous Chairman, Hugh Rienhoff, M.D. will continue to advise the company as a consultant. More

July 22, 2015
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
Wilson Therapeutics AB, a privately-held biopharmaceutical company developing novel treatments for patients with Wilson’s Disease, today announced the appointment of Dr. Carl Bjartmar as chief medical officer (CMO). Dr. Bjartmar will report to Jonas Hansson, chief executive officer, and will join the company’s management team. More

July 2, 2015
Wilson Therapeutics Appoints Hans Schikan to its Board of Directors
Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced the appointment of Hans Schikan to its board of directors. The appointment was approved by the shareholders during the Annual General Meeting on June 30. More

June 17, 2015
Wilson Therapeutics Announces Support of the BIG WOW to Raise Awareness of Wilson's Disease
STOCKHOLM, June 17, 2015 /PRNewswire/ -- Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG WOW). The event will take place on September 19, 2015 in sixteen cities across North America to increase awareness of Wilson's Disease and raise funds for the Wilson Disease Association. More

May 6, 2015
Wilson Therapeutics To Present As A "Next Wave" Company During BioEquity 2015 Conference In Vienna O
STOCKHOLM, May 6, 2015 /PRNewswire/ -- Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that CEO Jonas Hansson has been invited to present Wilson Therapeutics as a 'Next Wave' company during the annual BioEquity Conference, this year to be held in Vienna. The company will present at 14:30-14:40 CEST on May 19th. More

April 16, 2015
Wilson Therapeutics announces presentation of WTX101-201 Phase 2 study at the EASL 50th Internationa
STOCKHOLM, April 16, 2015 (PR NEWSWIRE) – Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company’s ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver (EASL), or the 50th International Liver Congress 2015, taking place in Vienna April 22-26. More

November 17, 2014
Wilson Therapeutics Launches Phase 2 Study in Wilson Disease
Wilson Therapeutics announces start of Phase 2 study to evaluate the efficacy and safety of WTX101 in newly diagnosed Wilson Disease patients. More

April 16, 2014
Wilson Therapeutics Secures $40 Million Private Financing for Wilson Disease Development Program
Wilson Therapeutics secures $40 million private financing to advance late stage development program for Wilson's Disease. More

January 13, 2014
Successful Filing of U.S. IND to Advance WTX101 Development Program for Wilson Disease
Wilson Therapeutics announces successful filing of U.S. IND to advance WTX101 development program for Wilson Disease. More

Data


23,644
Tech investments
From our Online Data Service
15,269
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 10€2.3MSoftware development
Dec 6€5.0MIT services
Dec 5€26.0MEnergy related
Dec 5€5.5MSecurity
Dec 5€16.0MKnowledge management
Dec 4€25.0MBiopharmaceuticals
Dec 4€8.0MInternet services

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises €37.5 million in series a

Apr 5
Fliit
logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...

Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...





About usContact usLegal Information
Copyright © 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.